Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01202136 · ClinicalTrials.gov registry record
The Clinical,Radiologic,Pathologic and Molecular Marker Characteristics of Pancreatic Cysts Study
A clinical trial, sponsored by Johns Hopkins University.
- Completed
- Registry status
- 477
- Enrollment target
NCT01202136: Completed study, sponsored by Johns Hopkins University.
NCT01202136 is a clinical trial that has completed, run by Johns Hopkins University. The registered enrollment target is 477 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01202136 has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- 477 participants
- Enrollment target
Study Summary
The aim is to propose and prospectively validate a diagnostic approach and model for prediction of mucinous versus non-mucinous, and malignant versus non-malignant pancreatic cysts using a combination of clinical, radiologic, and biomarker characteristics.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 477 participants |
| Start Date | 2012-10 |
| Est. Completion | 2019-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01202136
The ClinicalTrials.gov registry entry for NCT01202136 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 477 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01202136 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01202136 about?
NCT01202136 is a clinical study titled "The Clinical,Radiologic,Pathologic and Molecular Marker Characteristics of Pancreatic Cysts Study". The aim is to propose and prospectively validate a diagnostic approach and model for prediction of mucinous versus non-mucinous, and malignant versus non-malignant pancreatic cysts using a combination of clinical, radiologic, and biomarker characteristics.
What is the current status of trial NCT01202136?
This trial is currently completed. The enrollment target is 477 participants. The study started on 2012-10. Estimated completion is 2019-09.
Who is sponsoring clinical trial NCT01202136?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.